1,030
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson’s disease: an open-label study

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sun Ju Chung, Mahnaz Asgharnejad, Lars Bauer, Arturo Benitez, Babak Boroojerdi, Tanja Heidbrede, Allison Little & Han Joon Kim. (2017) Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective. Expert Review of Neurotherapeutics 17:7, pages 737-749.
Read now

Articles from other publishers (8)

Michael Bakker, Michaela E. Johnson, Lauren Corre, Deanna N. Mill, Xingzhuo Li, Richard J. Woodman & Jacinta L. Johnson. (2022) Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson’s disease population: A 3-year, multi-center study. PLOS ONE 17:5, pages e0267969.
Crossref
Wolfgang H. Jost. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 3293 3308 .
Vanessa Raeder, Iro Boura, Valentina Leta, Peter Jenner, Heinz Reichmann, Claudia Trenkwalder, Lisa Klingelhoefer & K. Ray Chaudhuri. (2021) Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience. CNS Drugs 35:2, pages 215-231.
Crossref
Wolfgang H. Jost. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 17 .
Govindarajan Karthivashan, Palanivel Ganesan, Shin-Young Park, Ho-Won Lee & Dong-Kug Choi. (2020) Lipid-based nanodelivery approaches for dopamine-replacement therapies in Parkinson's disease: From preclinical to translational studies. Biomaterials 232, pages 119704.
Crossref
James E. Frampton. (2019) Rotigotine Transdermal Patch: A Review in Parkinson’s Disease. CNS Drugs 33:7, pages 707-718.
Crossref
Ying Li, Danqing Wang, Shan Lu, Lijuan Zeng, Yu Wang, Wenting Song & Jianping Liu. (2018) Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism. European Journal of Pharmaceutical Sciences 124, pages 80-88.
Crossref
Jonathan Timpka, Ulrika Mundt-Petersen & Per Odin. (2016) Continuous dopaminergic stimulation therapy for Parkinson's disease – recent advances. Current Opinion in Neurology 29:4, pages 474-479.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.